Charles Swofford

Learn More
This study examined substance use among a group of 37 schizophrenia patients participating in a year-long fluphenazine decanoate (FD; Prolixin) dosage reduction study (Inderbitzin et al. (1994) Am. J. Psychiatry 151, 1753-1759). Ten (50%) of the 20 FD dose-reduced patients, and 6 (35%) of the 17 control group patients were identified as substance users. The(More)
OBJECTIVE This study evaluated the feasibility and impact of gradually reducing relatively high doses of fluphenazine decanoate by one-half for chronically impaired, poor inner-city patients with schizophrenia. METHOD Forty-three patients currently receiving an average of 23 mg (0.3 mg/kg) of fluphenazine decanoate every 2 weeks were divided alternately(More)
DEDICATION To my grandfathers who are not here to share in my accomplishments. v ACKNOWLEDGMENTS I would like to thank my advisor, Neil Forbes, for giving me the opportunity to work on this project, and providing guidance and support throughout my research. I could not have accomplished much without his mentorship and guidance. I would also like to thank(More)
  • 1